Taekyun Shin Selected Research

Hemorrhage

10/2020	Hesperidin improves motor disability in rat spinal cord injury through anti-inflammatory and antioxidant mechanism via Nrf-2/HO-1 pathway.
9/2017	Lithium ameliorates rat spinal cord injury by suppressing glycogen synthase kinase-3β and activating heme oxygenase-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taekyun Shin Research Topics

Disease

25	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2024 - 07/2003
22	Inflammation (Inflammations) 01/2024 - 02/2004
14	Neuroinflammatory Diseases 01/2024 - 05/2012
13	Experimental Autoimmune Neuritis 12/2012 - 05/2002
10	Spinal Cord Injuries (Spinal Cord Injury) 02/2022 - 10/2004
10	Neoplasms (Cancer) 10/2020 - 04/2005
9	Paralysis (Palsy) 01/2024 - 02/2004
8	Multiple Sclerosis 01/2024 - 07/2003
7	Body Weight (Weight, Body) 10/2020 - 02/2005
7	Gliosis 07/2019 - 02/2004
7	Memory Disorders (Memory Loss) 01/2016 - 09/2008
6	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 10/2011
6	Ganglion Cysts (Ganglion) 01/2012 - 01/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2020 - 12/2010
4	Fibrosis (Cirrhosis) 01/2023 - 06/2018
4	Myocarditis (Carditis) 10/2020 - 02/2004
4	Central Nervous System Diseases (CNS Diseases) 12/2019 - 07/2003
4	Cognitive Dysfunction 10/2018 - 02/2010
4	Spermatic Cord Torsion (Testicular Torsion) 04/2008 - 01/2005
3	Wounds and Injuries (Trauma) 01/2024 - 09/2008
3	Parkinson Disease (Parkinson's Disease) 06/2021 - 08/2020
3	Demyelinating Diseases (Demyelinating Disease) 12/2019 - 02/2004
3	Nervous System Diseases (Neurological Disorders) 01/2015 - 03/2009
3	Scrapie 06/2007 - 09/2004
3	Ischemia 06/2007 - 01/2005
2	AIDS-Related Complex (ARC) 03/2024 - 01/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2024 - 01/2005
2	Reperfusion Injury 01/2024 - 06/2007
2	Uveitis 01/2024 - 08/2021
2	Hemorrhage 10/2020 - 09/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 06/2018
2	Breast Neoplasms (Breast Cancer) 10/2018 - 10/2012
2	Carcinoma (Carcinomatosis) 09/2018 - 02/2014
2	Brain Injuries (Brain Injury) 03/2013 - 12/2004
2	Infections 09/2009 - 02/2006
2	Hypersensitivity (Allergy) 10/2005 - 03/2004
2	Cerebral Infarction 01/2005 - 10/2004
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Vision Disorders (Hemeralopia) 01/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
12	CytokinesIBA 03/2024 - 10/2004
8	OsteopontinIBA 07/2022 - 02/2004
8	Caveolin 1IBA 04/2007 - 08/2005
7	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2020 - 05/2002
6	EnzymesIBA 09/2017 - 08/2003
5	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2008
4	Messenger RNA (mRNA)IBA 03/2024 - 02/2006
4	Retinaldehyde (Retinal)IBA 01/2023 - 01/2006
4	Galectin 3 (LGALS3)IBA 06/2013 - 06/2007
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2006 - 05/2002
3	CollagenIBA 01/2023 - 10/2020
3	Mitogen-Activated Protein KinasesIBA 02/2022 - 07/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 09/2011
3	trimethyltinIBA 08/2021 - 12/2012
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2021 - 10/2012
3	Interleukin-6 (Interleukin 6)IBA 07/2020 - 09/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 01/2005
3	LithiumIBA 09/2017 - 01/2013
3	NestinIBA 10/2014 - 09/2004
3	Erythropoietin FDA Link 12/2012 - 03/2009
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2008 - 07/2003
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2005 - 08/2003
2	Therapeutic UsesIBA 01/2024 - 07/2020
2	EugenolIBA 01/2024 - 01/2024
2	Neuroprotective AgentsIBA 01/2024 - 12/2012
2	Fibronectins (Fibronectin)IBA 01/2023 - 03/2013
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2021
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 02/2022 - 07/2020
2	CalciumIBA 08/2021 - 10/2020
2	Lipoxygenase (Lipoxygenase-1)IBA 08/2021 - 02/2005
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2021 - 06/2021
2	PeriostinIBA 10/2020 - 10/2020
2	HesperidinIBA 10/2020 - 12/2019
2	AntioxidantsIBA 10/2020 - 12/2019
2	Olfactory Marker ProteinIBA 07/2019 - 02/2019
2	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 06/2018 - 07/2016
2	Glycogen Synthase KinasesIBA 09/2017 - 03/2017
2	Glycogen Synthase (Synthase I)IBA 09/2017 - 01/2013
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2015 - 02/2014
2	Protein Isoforms (Isoforms)IBA 01/2015 - 10/2011
2	Methotrexate (Mexate)FDA LinkGeneric 10/2012 - 07/2012
2	Arginine (L-Arginine)FDA Link 05/2012 - 03/2012
2	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 06/2011 - 09/2009
2	Netrin-1IBA 01/2011 - 03/2006
2	fucoidanIBA 03/2010 - 12/2008
2	Cathepsin DIBA 09/2008 - 06/2007
2	flotillinsIBA 06/2007 - 10/2006
2	Protein Kinases (Protein Kinase)IBA 03/2006 - 07/2003
2	Phosphotransferases (Kinase)IBA 09/2005 - 07/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2005 - 02/2004
2	Phospholipase DIBA 02/2004 - 01/2003
1	Peptides (Polypeptides)IBA 01/2024
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2024
1	C.I. direct red 80IBA 01/2023
1	norgalanthamineIBA 01/2023

Therapy/Procedure

5	Surgical Instruments (Clip) 01/2015 - 01/2003
3	Oral Administration 10/2020 - 02/2004
2	Drug Therapy (Chemotherapy) 10/2018 - 05/2010
2	Cranial Irradiation 01/2016 - 05/2015
2	Therapeutics 06/2014 - 01/2006